189 related articles for article (PubMed ID: 22479608)
1. Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression.
Cheng WL; Tsai MM; Tsai CY; Huang YH; Chen CY; Chi HC; Tseng YH; Chao IW; Lin WC; Wu SM; Liang Y; Liao CJ; Lin YH; Chung IH; Chen WJ; Lin PY; Wang CS; Lin KH
PLoS One; 2012; 7(3):e34352. PubMed ID: 22479608
[TBL] [Abstract][Full Text] [Related]
2. Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer.
Hosoda F; Arai Y; Okada N; Shimizu H; Miyamoto M; Kitagawa N; Katai H; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Ohki M; Shibata T
Oncogene; 2015 Feb; 34(9):1196-206. PubMed ID: 24662817
[TBL] [Abstract][Full Text] [Related]
3. Glyoxalase 1: Emerging biomarker and therapeutic target in cervical cancer progression.
Kim JY; Jung JH; Jung S; Lee S; Lee HA; Ouh YT; Hong SH
PLoS One; 2024; 19(6):e0299345. PubMed ID: 38870176
[TBL] [Abstract][Full Text] [Related]
4. High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.
Tian X; Wang Y; Ding X; Cheng W
J Neurosurg Sci; 2022 Jun; 66(3):228-233. PubMed ID: 31738028
[TBL] [Abstract][Full Text] [Related]
5. Glyoxalase I (GLO1) is up-regulated in pancreatic cancerous tissues compared with related non-cancerous tissues.
Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Akada J; Kitagawa T; Oka M; Nakamura K
Anticancer Res; 2012 Aug; 32(8):3219-22. PubMed ID: 22843895
[TBL] [Abstract][Full Text] [Related]
6. Glyoxalase 1 is up-regulated in hepatocellular carcinoma and is essential for HCC cell proliferation.
Hu X; Yang X; He Q; Chen Q; Yu L
Biotechnol Lett; 2014 Feb; 36(2):257-63. PubMed ID: 24158671
[TBL] [Abstract][Full Text] [Related]
7. GLO1 overexpression in human malignant melanoma.
Bair WB; Cabello CM; Uchida K; Bause AS; Wondrak GT
Melanoma Res; 2010 Apr; 20(2):85-96. PubMed ID: 20093988
[TBL] [Abstract][Full Text] [Related]
8. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
9. Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.
Zou XY; Ding D; Zhan N; Liu XM; Pan C; Xia YM
J Invest Dermatol; 2015 Feb; 135(2):589-598. PubMed ID: 25184957
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognosis of MYOZ2 in gastric cancer.
Li YF; Zhu GY; Ma Y; Qu HY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773
[TBL] [Abstract][Full Text] [Related]
11. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
[TBL] [Abstract][Full Text] [Related]
13. SETD2 indicates favourable prognosis in gastric cancer and suppresses cancer cell proliferation, migration, and invasion.
Chen Z; Raghoonundun C; Chen W; Zhang Y; Tang W; Fan X; Shi X
Biochem Biophys Res Commun; 2018 Apr; 498(3):579-585. PubMed ID: 29522714
[TBL] [Abstract][Full Text] [Related]
14. Exploring glyoxalase 1 expression in prostate cancer tissues: targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties.
Baunacke M; Horn LC; Trettner S; Engel KM; Hemdan NY; Wiechmann V; Stolzenburg JU; Bigl M; Birkenmeier G
Prostate; 2014 Jan; 74(1):48-60. PubMed ID: 24105621
[TBL] [Abstract][Full Text] [Related]
15. Beclin-1 expression is a significant predictor of survival in patients with lymph node-positive gastric cancer.
Geng QR; Xu DZ; He LJ; Lu JB; Zhou ZW; Zhan YQ; Lu Y
PLoS One; 2012; 7(9):e45968. PubMed ID: 23029344
[TBL] [Abstract][Full Text] [Related]
16. miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.
Lv N; Hao S; Luo C; Abukiwan A; Hao Y; Gai F; Huang W; Huang L; Xiao X; Eichmüller SB; He D
Sci China Life Sci; 2018 May; 61(5):541-549. PubMed ID: 29307109
[TBL] [Abstract][Full Text] [Related]
17. Glyoxalase 1 expression analysis by immunohistochemistry in breast cancer.
Scheifele C; Zhu Q; Ignatov A; Kalinski T; Nass N
Pathol Res Pract; 2020 Dec; 216(12):153257. PubMed ID: 33142109
[TBL] [Abstract][Full Text] [Related]
18. Expression of EphA1 in gastric carcinomas is associated with metastasis and survival.
Wang J; Dong Y; Wang X; Ma H; Sheng Z; Li G; Lu G; Sugimura H; Zhou X
Oncol Rep; 2010 Dec; 24(6):1577-84. PubMed ID: 21042754
[TBL] [Abstract][Full Text] [Related]
19. Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer.
Wei B; Shi H; Lu X; Shi A; Cheng Y; Dong L
Mol Med Rep; 2015 Aug; 12(2):2075-81. PubMed ID: 25847144
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the tumor promoter Glyoxalase-1 indicates poor prognosis in breast cancer.
Peng HT; Chen J; Liu TY; Wu YQ; Lin XH; Lai YH; Huang YF
Int J Clin Exp Pathol; 2017; 10(11):10852-10862. PubMed ID: 31966428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
